Upload
Featured Recent Articles Topics Login Upload

Search Results for 'studies safety'

studies safety published presentations and documents on DocSlides.

LIARS in Public Safety: Case Studies in Deception
LIARS in Public Safety: Case Studies in Deception
by celsa-spraggs
Stan Crowder, Ph.D.. Assistant Professor of Crimi...
Marc Bailie DVM, PhD
Marc Bailie DVM, PhD
by tawny-fly
Director In Vivo Facility Michigan State Universi...
Driver Education and Traffic Safety Programs: Findings from Recent Driver Education Studies
Driver Education and Traffic Safety Programs: Findings from Recent Driver Education Studies
by tawny-fly
American Driver and Traffic Safety Conference. Me...
Materion Brush Inc. Beryllium Health and Safety Update 08 April 2013
Materion Brush Inc. Beryllium Health and Safety Update 08 April 2013
by gristlydell
Health and Safety Update. 08 April 2013. Presented...
Drug Safety and PV Revision
Drug Safety and PV Revision
by BlueEyedBeauty
PGCPM Revision Module July 2019. With thanks to Ti...
Safety Considerations in Phase 1 Trials
Safety Considerations in Phase 1 Trials
by stefany-barnette
Sumathi Nambiar MD MPH. Director. Division of Ant...
Larson Institute Transportation Operations Program Safety Research
Larson Institute Transportation Operations Program Safety Research
by liane-varnes
Paul P Jovanis Professor Emeritus. Eric Donnell...
18 th Process Plant Safety Symposium
18 th Process Plant Safety Symposium
by debby-jeon
PPSS. PPSS . Chair and Vice-Chair. Chair:. Kathy ...
Larson Institute Transportation Operations Program Safety Research
Larson Institute Transportation Operations Program Safety Research
by stefany-barnette
Paul P Jovanis Professor Emeritus. Eric Donnell...
Safety of food additives: The regulatory Roadmap
Safety of food additives: The regulatory Roadmap
by mitsue-stanley
Manojit Basu, PhD . Grocery Manufacturers Associa...
Safety of food additives: The regulatory Roadmap
Safety of food additives: The regulatory Roadmap
by kittie-lecroy
Manojit Basu, PhD . Grocery Manufacturers Associa...
Iowa Traffic Safety Improvement Program
Iowa Traffic Safety Improvement Program
by olivia-moreira
FY 2017 Program Proposal. Office. of Traffic and...
Eric Silberhorn, Ph.D. Environmental Safety Team
Eric Silberhorn, Ph.D. Environmental Safety Team
by jane-oiler
Division of Scientific Support. Office of New Ani...
1 Immunogenicity The key safety issue for biosimilars
1 Immunogenicity The key safety issue for biosimilars
by gelbero
Prof. Ibrahim A. . Alsarra. Professor . of . Phar...
Evidence Report
Evidence Report
by kylie
Narcolepsy (with and without Cataplexy) and Comme...
Official address
Official address
by delilah
Domenico Scarlattilaan 6 1083 HS Amsterdam The Ne...
Introduction In two-thirds of the United States (U.S.) medical cannabis is available by physician o
Introduction In two-thirds of the United States (U.S.) medical cannabis is available by physician o
by vestibulephilips
Qualifying medical conditions are typically define...
Drug-Induced Cardiac Safety in premature infants and neonates
Drug-Induced Cardiac Safety in premature infants and neonates
by easyho
Luana Pesco Koplowitz, MD, PhD, FCP, FFPM. Preside...
Biosimilars in emerging markets- regulatory and Commercial considerations
Biosimilars in emerging markets- regulatory and Commercial considerations
by jane-oiler
OMIC Group. Biosimilars 2104. Hyderabad. India. 2...
Making a Medicine: The basic principles
Making a Medicine: The basic principles
by debby-jeon
of . medicine discovery . and . development. It t...
Meta-Analysis of Clinical Data for Regulated Biopharmaceutical Products:  
Meta-Analysis of Clinical Data for Regulated Biopharmaceutical Products:  
by cheryl-pisano
Answers to Frequently Asked Questions. Brenda Cro...
Eric Silberhorn, Ph.D. Environmental Safety Team
Eric Silberhorn, Ph.D. Environmental Safety Team
by liane-varnes
Division of Scientific Support. Office of New Ani...
Efficacy and Safety of Low Molecular Weight Heparin compared to Unfractionated Heparin for Chronic
Efficacy and Safety of Low Molecular Weight Heparin compared to Unfractionated Heparin for Chronic
by mitsue-stanley
R. eview and Meta-Analysis.. Dinesh Keerty, MD. T...
1 Christopher Loss, DVM Division of Therapeutic Drugs for Non-Food Animals
1 Christopher Loss, DVM Division of Therapeutic Drugs for Non-Food Animals
by yoshiko-marsland
Office of New Animal Drug Evaluation. USFDA Cente...
Understanding the Risk Assessment Process
Understanding the Risk Assessment Process
by tatiana-dople
Mitchell A. Cheeseman, PhD. Managing Director, E&...
Meta-Analysis of Clinical Data for Regulated Biopharmaceuti
Meta-Analysis of Clinical Data for Regulated Biopharmaceuti
by min-jolicoeur
Answers to Frequently Asked Questions. Brenda Cro...
Suppression – HRD canisters
Suppression – HRD canisters
by calandra-battersby
1. Prevention and Mitigation. Suppression sequenc...
Large Phase 1 Studies with Expansion Cohorts: Clinical, Eth
Large Phase 1 Studies with Expansion Cohorts: Clinical, Eth
by karlyn-bohler
Perspectives. Accelerating . Anticancer Agent Dev...
Differences Between Strategic and Tactical Development of V
Differences Between Strategic and Tactical Development of V
by trish-goza
Melanie Hartsough, Ph.D.. Biologics Consulting Gr...
Risk Summit 2011
Risk Summit 2011
by pamella-moone
Integrating Safety. Into Operations. A Systems Th...
Materion
Materion
by yoshiko-marsland
Brush Inc.. Beryllium . Health and Safety Update...
OSWG’s Role in Shaping the Regulatory Development of
OSWG’s Role in Shaping the Regulatory Development of
by davies
Oligos. . - . A Potential Model for Moving Forwar...
INTRODUCTION TO DRUG REGULATORY SYSTEM.
INTRODUCTION TO DRUG REGULATORY SYSTEM.
by levi903
Drug Regulation means the control of Drug by regul...
Clemensia Nakabiito ,
Clemensia Nakabiito ,
by anastasia
MBChB, . Mmed. Phionah Kibalama Ssemambo, MPH, MBC...
Genotoxicity and Industry:
Genotoxicity and Industry:
by deena
Utilizing genetic toxicity assays to . support pha...
The opinions expressed in the studies are those of the consultant and
The opinions expressed in the studies are those of the consultant and
by piper
the CommissionVAMOSVolunteers always on the move f...
1 Structure and mandate of FDA
1 Structure and mandate of FDA
by sherrill-nordquist
Leonard Sacks. Office of Medical Policy. CDER, FD...
Laura L. Hungerford, DVM, MPH, PhD
Laura L. Hungerford, DVM, MPH, PhD
by tatiana-dople
Senior Advisor, Science and Policy, ONADE. Profes...
A Partnership Between Academia and Industry
A Partnership Between Academia and Industry
by lindy-dunigan
Ashleigh, Bussey, Putsman and Townsend . Research...
Everybody’s Different
Everybody’s Different
by lindy-dunigan
But We all Bleed Red. It’s in Our Culture. Hier...